Learn Before
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures
Kenneth H. Dinnon III, Sarah R. Leist, Alexandra Schäfer, Caitlin E. Edwards, David R. Martinez, Stephanie A. Montgomery, Ande West, Boyd L. Yount Jr, Yixuan J. Hou, Lily E. Adams, Kendra L. Gully, Ariane J. Brown, Emily Huang, Matthew D. Bryant, Ingrid C. Choong, Jeffrey S. Glenn, Lisa E. Gralinski, Timothy P. Sheahan, Ralph S. Baric bioRxiv 2020.05.06.081497; doi: https://doi.org/10.1101/2020.05.06.081497
0
1
Tags
SARS-CoV-2 (COVID-19)
Biomedical Sciences
Related
Lack of Reinfection in Rhesus Macaques Infected with SARS-CoV-2
Aerodynamic Characteristics and RNA Concentration of SARS-CoV-2 Aerosol in Wuhan Hospitals during COVID-19 Outbreak
Comparative genomic analysis revealed specific mutation pattern between human coronavirus SARS-CoV-2 and Bat-SARSr-CoV RaTG13
Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis
Virus-Receptor Interactions of Glycosylated SARS-CoV-2 Spike and Human ACE2 Receptor
A mouse-adapted SARS-CoV-2 model for the evaluation of COVID-19 medical countermeasures